Valsartan Tablets, USP, 160 mg, 90-count bottles, Rx Only, Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd, Xunqiao, Linhai, Zhejiang 317024, China; Distributed by: Solco Healthcare US, LLC, Cranbury, NJ 08512, USA; NDC 43547-369-09.
Published January 17, 2018 · Recall initiated: November 29, 2017
Summary
FDA records drug Class II recall D-0209-2018, published January 17, 2018 and initiated November 29, 2017. Recalling firm: Prinston Pharmaceutical Inc; Status: Terminated; Reported quantity: 21,987 bottles; Lot: Lot #: 343B17025, Exp 03/31/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsule Specifications: confirmed customer complaint of thicker and heavier tablets in bottle.
What to do
Voluntary: Firm initiated · Letter
Get an email if VALSARTAN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- VALSARTAN
- Manufacturer
- Prinston Pharmaceutical Inc
- Distributor
- Nationwide in the USA and Puerto Rico
- UPC
- 0343547370039
- Lot
- Lot #: 343B17025, Exp 03/31/19
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAValsartan Tablets USP 40 mg, 30 count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJMarch 27, 2019
- FDAValsartan tablets USP 320 mg, 90-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton,January 23, 2019
- FDAValsartan Tablets, USP, 320 mg, 90-count bottle, Rx Only, Made in India, Manufactured for: MylanDecember 19, 2018
- FDAValsartan Tablets, USP 80 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: MylanDecember 19, 2018
- FDAMoexipril Hydrochloride and Hydrocholorothiazide Tablets USP, 7.5 mg/12.5 mg, 100-count bottle, Rx only,January 17, 2018
- FDAGabapentin Oral Solution, 250 mg/5 mL (50 mg/mL) in a 470 mL amber-colored bottle, Rx Only. Manufactured by:January 17, 2018
Questions about this recall
Was Valsartan Tablets, USP, 160 mg, 90-count bottles, Rx Only, Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd, Xunqiao, Linhai, Zhejiang 317024, China; Distributed by: Solco Healthcare US, LLC, Cranbury, NJ 08512, USA; NDC 43547-369-09. recalled?
Yes. FDA published recall D-0209-2018 on January 17, 2018. Reported hazard: Failed Tablet/Capsule Specifications: confirmed customer complaint of thicker and heavier tablets in bottle.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: VALSARTAN. UPC: 0343547370039.